Hint mode is switched on Switch off

Immunic, ordinary share
IMUX, US4525EP1011

Add a stock to WL
Choose all Reset all
Immunic, сountry — USA
27/04/2026 stock stopped trading due to affiliation to Immunic, ordinary share
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Immunic, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases including ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
  • Issuer
  • Full borrower / issuer name
    Immunic, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    IMUX
  • Placement
    27.04.2020
  • Lock up period
    180
  • Number of papers
    1,764,706
  • Volume of raised funds
    15 mln USD
  • Placement share
    13.79%
  • Final placement price
    8.5 USD
  • Price change since placement date
    -100%
  • By capitalization
    108.74 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    IMUX
  • Placement
    16.07.2021
  • Lock up period
    180
  • Number of papers
    4,500,000
  • Volume of raised funds
    45 mln USD
  • Placement share
    17.14%
  • Final placement price
    10 USD
  • Price change since placement date
    -100%
  • By capitalization
    262.49 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    IMUX
  • Placement
    09.04.2025
  • Lock up period
    180
  • Number of papers
    5,666,667
  • Volume of raised funds
    5.1 mln USD
  • Placement share
    5.91%
  • Final placement price
    0.9 USD
  • Price change since placement date
    -100%
  • By capitalization
    86.24 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Indicators

News

29/06/2026 Immunic: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
28/05/2026 Immunic: Regulation Fd Disclosure, Financial Statements And Exhibits
28/04/2026 Immunic, Inc. (NASDAQ: IMUX) Executes Reverse Stock Split to Boost Share Price
24/04/2026 Immunic: Departure Of Directors Or Principal Officers; Election Of Directors; Appointment Of Principal Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
22/04/2026 Immunic: Material Modification To Rights Of Security Holders, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Other Events, Financial Statements And Exhibits
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.